Liver SVCT Systems: Vitamin C Uptake, Roles & Regulation
肝脏 SVCT 系统:维生素 C 摄取、作用
基本信息
- 批准号:7787060
- 负责人:
- 金额:$ 12.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:Alcoholic liver damageAntioxidantsAscorbic AcidAscorbic Acid DeficiencyAtherosclerosisBiochemical ReactionBiologyCardiovascular DiseasesCataractCellsCharacteristicsClinicalConnective Tissue DiseasesDiabetes MellitusDiseaseFatty LiverFree Radical ScavengersGall Bladder DiseasesGenesGenetic TechniquesGoalsGrantHepatitisHepatocyteHistologyHomeostasisHumanImpaired wound healingIn VitroInvestigationKineticsKnock-outKnowledgeLearningLiverLiver diseasesMalignant NeoplasmsMammalsMediatingMicronutrientsMolecularMolecular BiologyMusNatureNucleic Acid Regulatory SequencesNutrientPathologyPatientsPhysiologicalPhysiologyPlayPrincipal InvestigatorProcessProtein IsoformsRegulationRelative (related person)ResearchResearch DesignResearch PersonnelResearch TrainingRoleSiteSmall Interfering RNASodiumSourceSystemTestingTissuesTrainingVasomotorVitaminsWater-Soluble VitaminWorkbasebonecareercareer developmentclinically relevantclinically significantcofactordesignhuman diseasein vitro Modelin vitro activityin vivoin vivo Modelmouse modelnon-alcoholicproblem drinkerprogramspromoterprotective effectsodium DEPENDENDENT vitamin C transporter 1sodium-dependent vitamin C transporter 2uptake
项目摘要
This proposal has been designed to advance the Principle Investigator (PI)towards his goal of academic
independence. To attain that objective he will learn advanced molecular biology and mouse genetic
techniques as well as liver pathology/histology in his studies of vitamin C regulation in the liver. Ascorbic acid
(vitamin C) is a required essential micronutrient and effective antioxidant in humans. Two isoforms of the
sodium-dependent vitamin C transporters (SVCT1 and SVCT2) are expressed in many human and mouse
tissues, including the liver. Nothing is known regarding the regulation or relative contribution of the SVCT
systems toward the overall vitamin C uptake process in the liver. Understanding these mechanisms is
clinically relevant since many liver related diseases benefit from optimizing vitamin C body homeostasis. Our
studies will use both an in vitro and in vivo approach to perform a comprehensive examination of the human
liver vitamin C uptake process and regulation. We will determine the characteristics/kinetics of vitamin C
uptake, characterize the hSVCTI and hSVCT2promoters, establish the relative contribution of hSVCTI and
hSVCT2 towardtotal uptake using an siRNA approach and perform studies regardingthe effects of adaptive
regulation of the vitamin C uptake process, all in human liver cells. In addition we will determine the
characteristics/kinetics of vitamin C uptake in the liver of an in vivo mouse model that like humans is unable
to synthesize vitamin C, establish the relative contribution of mSVCTI and mSVCT2 toward total uptake
using the cre/lox system to generate liver specific knockouts of each gene independently, and continue our
studies into adaptive regulation of vitamin C uptake in this in vivo model. Our studies into the mechanisms
involved in maintaining and regulating normal vitamin C body homeostasis will potentially allow clinicians to
develop effective strategies for patients during conditions of deficiency. The extensive training and
educational opportunities will allow the PI to launch into a career as an independent academic researcher.
该建议旨在将主要研究者(PI)推向其学术目标
独立。为了实现这个目标,他将学习高级分子生物学和小鼠遗传
在肝脏中维生素C调节的研究中,技术以及肝脏病理学/组织学。抗坏血酸
(维生素C)是人类必需的必需微量营养素和有效的抗氧化剂。两个同工型
依赖钠的维生素C转运蛋白(SVCT1和SVCT2)在许多人和小鼠中表达
组织,包括肝脏。关于SVCT的调节或相对贡献,尚无任何了解
肝脏中整体维生素C摄取过程的系统。了解这些机制是
临床相关,因为许多肝相关疾病受益于优化维生素C身体稳态。我们的
研究将同时使用体外和体内方法对人进行全面检查
肝脏维生素C摄取过程和调节。我们将确定维生素C的特征/动力学
摄取,表征HSVCTI和HSVCT2启动器,建立HSVCTI和
HSVCT2使用siRNA方法截至摄取,并进行有关适应性影响的研究
调节维生素C摄取过程,全部在人肝细胞中。此外,我们将确定
体内小鼠模型的肝脏中维生素C摄取的特征/动力学,就像人类无法
为了合成维生素C,建立MSVCTI和MSVCT2对总摄取的相对贡献
使用CRE/LOX系统独立生成每个基因的肝脏特异性敲除,并继续我们的
研究该体内模型中维生素C摄取的适应性调节。我们对机制的研究
参与维持和调节正常维生素C身体体内平衡,可能会使临床医生能够
在缺乏状态下为患者制定有效的策略。广泛的培训和
教育机会将使PI成为独立学术研究员的职业。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Promoter analysis of the human ascorbic acid transporters SVCT1 and 2: mechanisms of adaptive regulation in liver epithelial cells.
- DOI:10.1016/j.jnutbio.2010.03.001
- 发表时间:2011-04
- 期刊:
- 影响因子:5.6
- 作者:Reidling, Jack C.;Rubin, Stanley A.
- 通讯作者:Rubin, Stanley A.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JACK C REIDLING其他文献
JACK C REIDLING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JACK C REIDLING', 18)}}的其他基金
Liver SVCT Systems: Vitamin C Uptake, Roles & Regulation
肝脏 SVCT 系统:维生素 C 摄取、作用
- 批准号:
7367058 - 财政年份:2006
- 资助金额:
$ 12.58万 - 项目类别:
Liver SVCT Systems: Vitamin C Uptake, Roles & Regulation
肝脏 SVCT 系统:维生素 C 摄取、作用
- 批准号:
7587988 - 财政年份:2006
- 资助金额:
$ 12.58万 - 项目类别:
Liver SVCT Systems: Vitamin C Uptake, Roles & Regulation
肝脏 SVCT 系统:维生素 C 摄取、作用
- 批准号:
7013031 - 财政年份:2006
- 资助金额:
$ 12.58万 - 项目类别:
Liver SVCT Systems: Vitamin C Uptake, Roles & Regulation
肝脏 SVCT 系统:维生素 C 摄取、作用
- 批准号:
7195720 - 财政年份:2006
- 资助金额:
$ 12.58万 - 项目类别:
Molecular Characterization of the SLC19A2 Promoter
SLC19A2 启动子的分子表征
- 批准号:
6646808 - 财政年份:2003
- 资助金额:
$ 12.58万 - 项目类别:
Molecular Characterization of the SLC19A2 Promoter
SLC19A2 启动子的分子表征
- 批准号:
6768641 - 财政年份:2003
- 资助金额:
$ 12.58万 - 项目类别:
Molecular Characterization of the SLC19A2 Promoter
SLC19A2 启动子的分子表征
- 批准号:
6896106 - 财政年份:2003
- 资助金额:
$ 12.58万 - 项目类别:
相似国自然基金
抗氧化剂/活性离子时序释放复合支架构建及其修复糖尿病骨缺损的机制研究
- 批准号:32360232
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
塑料抗氧化剂内分泌干扰转化产物的识别与环境行为研究
- 批准号:22306042
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
农用地膜抗氧化剂的土壤污染特征及其微生物效应与机制研究
- 批准号:42377223
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
自然水体轮胎抗氧化剂高毒醌类衍生物非靶向识别及生物转化机制
- 批准号:42377360
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
取代对苯二胺抗氧化剂及其醌衍生物的人体内暴露标志物研究
- 批准号:22306031
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Enhancing TET activity for the treatment of hematological malignancy
增强 TET 活性治疗血液恶性肿瘤
- 批准号:
10717715 - 财政年份:2023
- 资助金额:
$ 12.58万 - 项目类别:
Theranostic Metabolic Imaging of Oxidative Stress in Multiple Sclerosis.
多发性硬化症氧化应激的治疗诊断代谢成像。
- 批准号:
10666890 - 财政年份:2023
- 资助金额:
$ 12.58万 - 项目类别:
Passive heat therapy for lowering systolic blood pressure and improving vascular function in mid-life and older adults
被动热疗可降低中年和老年人的收缩压并改善血管功能
- 批准号:
10596067 - 财政年份:2022
- 资助金额:
$ 12.58万 - 项目类别:
Project 2: The role of the DNA damage response in clonal competition following genotoxic stress
项目 2:DNA 损伤反应在基因毒性应激后克隆竞争中的作用
- 批准号:
10332336 - 财政年份:2022
- 资助金额:
$ 12.58万 - 项目类别:
Development of a multi-modal targeted nanotherapeutic to prevent restenosis in an atherosclerotic environment
开发多模式靶向纳米治疗药物以预防动脉粥样硬化环境中的再狭窄
- 批准号:
10667411 - 财政年份:2022
- 资助金额:
$ 12.58万 - 项目类别: